{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:08:56Z","timestamp":1787508536612,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cllc.2011.03.026","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T12:18:36Z","timestamp":1305893916000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non\u2013Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database"],"prefix":"10.1016","volume":"12","author":[{"given":"Maria","family":"Werner-Wasik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Walter J.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Byhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2011.03.026_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0360-3016(98)00251-X","article-title":"Response, toxicity, failure patterns, and survival in five RTOG trials of sequential and\/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung","volume":"42","author":"Byhardt","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib2","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.1998.16.10.3316","article-title":"Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer","volume":"16","author":"Choy","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(99)00031-0","article-title":"Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and\/or hyperfractionated radiotherapy: A multivariate analysis of 1076 RTOG patients","volume":"44","author":"Werner-Wasik","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib4","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1200\/JCO.1998.16.9.3082","article-title":"Patient-reported short-term and long-term physical and psychologic symptoms: results of the Continuous Hyperfractionated Accelerated Radiotherapy (CHART) randomized trial in non-small cell lung cancer","volume":"16","author":"Bailey","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib6","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/1097-0142(19950501)75:9<2337::AID-CNCR2820750924>3.0.CO;2-K","article-title":"Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer","volume":"75","author":"Byhardt","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2011.03.026_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.1996.14.4.1055","article-title":"Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06","volume":"14","author":"Lee","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0360-3016(02)02793-1","article-title":"Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04","volume":"53","author":"Komaki","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib9","first-page":"484a","article-title":"Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: initial report of RTOG 9410","volume":"19","author":"Curran","year":"2000","journal-title":"Proc ASCO"},{"key":"10.1016\/j.cllc.2011.03.026_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2307\/2529934","article-title":"Hazard rate models with covariates","volume":"35","author":"Prentice","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.cllc.2011.03.026_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0360-3016(93)90371-2","article-title":"Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 RTOG trials","volume":"27","author":"Cox","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0360-3016(98)00283-1","article-title":"Concurrent radiochemotherapy for patients with Stage III non-small cell lung cancer: Long term results of a Phase II study","volume":"42","author":"Jeremic","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0360-3016(00)00420-X","article-title":"A Phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced non-small cell lung cancer (A Vanderbilt Cancer Center Affiliate Network Study)","volume":"47","author":"Choy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0360-3016(98)00247-8","article-title":"A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small cell lung cancer: A 5-year follow-up report","volume":"42","author":"Lee","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0360-3016(94)90568-1","article-title":"Morphological correlates of fractionated radiation of the mouse lung: early and late effects","volume":"29","author":"Penney","year":"1994","journal-title":"Int J Radiat Oncol Biol"},{"key":"10.1016\/j.cllc.2011.03.026_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2011.03.026_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0360-3016(99)00163-7","article-title":"Clinical and dosimetric predictors of radiation-induced esophageal injury","volume":"45","author":"Maguire","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0360-3016(00)00699-4","article-title":"Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: A multivariate analysis of patients with lung cancer treated with non-operative therapy","volume":"48","author":"Werner-Wasik","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.03.021","article-title":"Acute esophageal toxicity in non-small cell lung cancer patients after high-dose conformal radiotherapy","volume":"75","author":"Belderbos","year":"2005","journal-title":"Radiother and Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0360-3016(02)03937-8","article-title":"Predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three-dimensional conformal radiotherapy","volume":"55","author":"Singh","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ijrobp.2004.12.025","article-title":"Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy","volume":"62","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2004.06.014","article-title":"Dosimetric and clinical predictors for radiation-induced esophageal injury","volume":"61","author":"Ahn","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2003.09.080","article-title":"Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma","volume":"58","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2006.04.022","article-title":"Risk factors for acute esophagitis in non-small cell lung cancer patients treated with concurrent chemotherapy and three-dimensional radiotherapy","volume":"66","author":"Wei","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0360-3016(99)00183-2","article-title":"Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer","volume":"45","author":"Graham","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2006.07.1337","article-title":"Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small cell lung cancer treated with concurrent chemotherapy and three-dimensional conformal radiotherapy","volume":"66","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(98)00196-5","article-title":"Radiation pneumonitis as a function of mean lung dose; An analysis of pooled data of 540 patients","volume":"42","author":"Kwa","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","article-title":"Comparing different NTCP models that predict the incidence of radiation pneumonitis","volume":"55","author":"Seppenwoolde","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","article-title":"Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer \u2013 a systematic review","volume":"71","author":"Rodrigues","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0360-3016(97)00741-4","article-title":"Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: Evidence for inherent interindividual variation","volume":"41","author":"Geara","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib33","series-title":"Pulmonary effects of radiotherapy in patients with inoperable bronchial carcinoma [PhD Thesis]","author":"Helle","year":"1995"},{"key":"10.1016\/j.cllc.2011.03.026_bib34","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.1995.13.10.2606","article-title":"Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors","volume":"13","author":"Roach","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(01)01524-3","article-title":"Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor beta","volume":"50","author":"Fu","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib36","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1200\/JCO.2005.01.7145","article-title":"Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis","volume":"23","author":"Arpin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.026_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijrobp.2009.04.029","article-title":"A phase I\/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117","volume":"77","author":"Bradley","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.03.026_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3816\/CLC.2006.n.039","article-title":"Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504)","volume":"8","author":"Gandara","year":"2006","journal-title":"Clin Lung Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:53:47Z","timestamp":1761504827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1525730411000271"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2011.03.026","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non\u2013Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2011.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}